By mapping 14 metabolic pathways and 150+ genetic insights, PlexusDx helps determine whether traditional semaglutide, tirzepatide, or a dual-compound approach suits your physiology best
The result is greater weight loss than single-action GLP-1 drugs in clinical trials the SURMOUNT-1 trial reported average weight loss of 22.5% over 72 weeks at the 15 mg dose, compared to roughly 15% for semaglutides STEP-1 trial
This ensures you have a stable reference point
Mounjaro activates receptors for both the hormones GLP-1 and GIP and leads to improved blood sugar control
Increased water intake has no proven effect on metformin-related sweating, though individual responses may vary
At Contour Medical Spa, we are dedicated to offering the most advanced, evidence-based treatments to help our clients achieve their health and aesthetic goals